180 Wealth Advisors, LLC Novo Nordisk A S Transaction History

180 Wealth Advisors, LLC

$629 Million
Q3 2024

A detailed history of 180 Wealth Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, 180 Wealth Advisors, LLC holds 4,805 shares of NVO stock, worth $504,813. This represents 0.09% of its overall portfolio holdings.

Number of Shares

4,805

Previous 4,843 0.78%

Holding current value

$504,813

Previous $691,000 17.22%

% of portfolio

0.09%

Previous 0.12%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$119.07 - $145.42 $4,524 - $5,525	-38 Reduced 0.78%	4,805 $572,000
Q2 2024 Jul 16, 2024	SELL	$122.71 - $146.91 $209,343 - $250,628	-1,706 Reduced 26.05%	4,843 $691,000
Q1 2024 Apr 15, 2024	BUY	$102.11 - $135.92 $22,770 - $30,310	223 Added 3.53%	6,549 $840,000
Q4 2023 Jan 24, 2024	SELL	$87.78 - $105.45 $15,273 - $18,348	-174 Reduced 2.68%	6,326 $654,000
Q3 2023 Oct 31, 2023	BUY	$90.94 - $199.54 $328,384 - $720,538	3,611 Added 124.99%	6,500 $591,000
Q2 2023 Jul 11, 2023	SELL	$155.98 - $172.65 $236,465 - $261,737	-1,516 Reduced 34.42%	2,889 $467,000
Q1 2023 Apr 07, 2023	SELL	$132.34 - $159.14 $10,587 - $12,731	-80 Reduced 1.78%	4,405 $701,000
Q4 2022 Feb 02, 2023	SELL	$102.55 - $135.33 $37,840 - $49,936	-369 Reduced 7.6%	4,485 $606,000
Q3 2022 Oct 12, 2022	SELL	$95.28 - $116.93 $44,209 - $54,255	-464 Reduced 8.73%	4,854 $484,000
Q2 2022 Jul 11, 2022	SELL	$103.24 - $121.81 $7,639 - $9,013	-74 Reduced 1.37%	5,318 $594,000
Q1 2022 Apr 22, 2022	SELL	$93.1 - $112.54 $5,865 - $7,090	-63 Reduced 1.15%	5,392 $617,000
Q4 2021 Jan 26, 2022	SELL	$95.88 - $117.08 $62,609 - $76,453	-653 Reduced 10.69%	5,455 $520,000
Q2 2021 Aug 13, 2021	SELL	$67.66 - $84.76 $13,464 - $16,867	-199 Reduced 3.16%	6,108 $611,000
Q1 2021 May 25, 2021	SELL	$67.06 - $75.82 $16,630 - $18,803	-248 Reduced 3.78%	6,307 $513,000
Q4 2020 Jan 27, 2021	SELL	$63.89 - $73.8 $1,533 - $1,771	-24 Reduced 0.36%	6,555 $479,000
Q3 2020 Oct 23, 2020	BUY	$63.69 - $70.22 $122,539 - $135,103	1,924 Added 41.33%	6,579 $469,000
Q2 2020 Jul 21, 2020	SELL	$58.54 - $67.94 $25,991 - $30,165	-444 Reduced 8.71%	4,655 $313,000
Q1 2020 Apr 09, 2020	SELL	$49.46 - $64.78 $4,946 - $6,478	-100 Reduced 1.92%	5,099 $302,000
Q4 2019 Jan 17, 2020	BUY	$49.86 - $58.26 $27,273 - $31,868	547 Added 11.76%	5,199 $324,000
Q3 2019 Oct 22, 2019	BUY	$47.54 - $53.43 $221,156 - $248,556	4,652 New	4,652 $238,000
Q1 2019 May 14, 2019	SELL	$46.36 - $52.63 $199,069 - $225,993	-4,294 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$46.76 - $51.24 $17,394 - $19,061	-372 Reduced 7.97%	4,294 $202,000
Q2 2018 Aug 08, 2018	BUY	$44.29 - $50.42 $206,657 - $235,259	4,666 New	4,666 $215,000

Others Institutions Holding NVO

# of Institutions

1,954

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $237B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of 180 Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 180 Wealth Advisors, LLC with notifications on news.

Account

180 Wealth Advisors, LLC Novo Nordisk A S Transaction History